The biological and diagnostic roles of MicroRNAs in meningiomas

Lei Wang1, Shengpan Chen2,3, Yan Liu4

  • 1Department of Neurosurgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.

Insights

MicroRNAs (miRNAs) are small RNAs regulating genes. This review explores their role in meningioma, highlighting their potential as diagnostic biomarkers and therapeutic targets for this brain tumor.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
  • miRNAs are implicated in tumorigenesis and cancer progression.
  • The specific roles and mechanisms of miRNA dysregulation in meningioma pathogenesis remain unclear.

Purpose of the Study:

  • To review aberrant miRNA expression in meningioma identified by high-throughput microarray profiling.
  • To explore the potential of miRNAs as biomarkers and therapeutic targets for meningioma.
  • To summarize mechanisms of miRNA-mediated meningioma occurrence and progression.

Main Methods:

  • Literature review of existing research on meningioma and miRNA.
  • Analysis of high-throughput microarray data for aberrantly expressed miRNAs in meningioma.
  • Synthesis of recent studies on miRNA-mediated mechanisms in meningioma.

Main Results:

  • Identified several aberrantly expressed miRNAs in meningioma through microarray profiling.
  • Highlighted the potential of specific miRNAs as diagnostic biomarkers.
  • Indicated the therapeutic potential of targeting miRNAs in meningioma treatment.

Conclusions:

  • miRNA deregulation is a significant factor in meningioma development and progression.
  • miRNAs hold promise as novel biomarkers for meningioma diagnosis.
  • Targeting miRNAs could offer new therapeutic strategies for meningioma.